Juan-José Pérez-Ruixo

26PUBLICATIONS
43CO-AUTHORS
PharmacogenomicsEpidemiological modellingApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular medicineMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jul 02, 2026
Population pharmacokinetics and pharmacodynamics of canagliflozin in paediatric patients with type 2 diabetes mellitus.

|Dec 23, 2025
Mechanistic Population Pharmacokinetic-Pharmacodynamic Model of the Tau-Targeted Antibody Posdinemab in Healthy Participants and Participants with Alzheimer's Disease.

Carlos Pérez-Ruixo, Lingjue Li, Wendy R Galpern

|Sep 17, 2025
Nipocalimab Dose Selection in Generalized Myasthenia Gravis.

Belén Valenzuela, Martine Neyens, Yaowei Zhu

|Sep 06, 2025
A Randomized Trial on the Combined Effect of Ponesimod and Propranolol on Heart Rate, Cardiac Safety, and Pharmacokinetics in Healthy Adults.

Sivi Ouwerkerk-Mahadevan, Tessa Hosman, Italo Poggesi

|Jul 04, 2025
Population Pharmacokinetic and Exposure-Response Analyses of Ibrutinib Combined With Bendamustine and Rituximab in Patients With Mantle Cell Lymphoma.

Per Olsson Gisleskog, Belén Valenzuela, Nicoline Treijtel

|May 15, 2025
Population Pharmacokinetics of siRNA JNJ-73763989 in Healthy Participants and Patients With Chronic Hepatitis B.

Tetsuro Ogawa, Nele Goeyvaerts, Thomas N Kakuda

Pageof 5

Frequent Collaborators

8 joint publications

Belén Valenzuela

5 joint publications

Oliver Ackaert

5 joint publications

Italo Poggesi

5 joint publications

Per Olsson Gisleskog